1,643 results on '"Pfreundschuh, Michael"'
Search Results
102. Fast-Track Schedule for Vitamin D3 Substitution in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
103. VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B‐cell lymphoma
104. ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
105. Analysis of the antibody repertoire of lymphoma patients
106. A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing
107. Therapeutic strategies for agressive lymphomas: The trials of the DSHNHL
108. Chromosomal localization and promoter analysis of the adenomatous polyposis coli binding protein RP1
109. Targeting properties of an anti-CD16/anti-CD30 bispecific antibody in an in vivo system
110. Anschriften der Herausgeber und Autoren
111. Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma
112. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group
113. Gene-modified spontaneous Epstein-Barr virus-transformed lymphoblastoid cell lines as autologous cancer vaccines: Mutated p21 ras oncogene as a model
114. Der Zeitfaktor in der Onkologie: Spielt die Gesamtbehandlungszeit in der Chemotherapie eine Rolle?
115. Immune recruitment by bispecific antibodies for the treatment of Hodgkin disease
116. Exploitation of the B cell repertoire for the identification of human tumor antigens
117. Initiation of humoral and cellular immune responses in patients with refractory Hodgkin's disease by treatment with an anti-CD16/CD30 bispecific antibody
118. SEREX
119. Enrichment polymerase chain reaction for the detection of Ki-ras mutations: relevance of Taq polymerase error rate, initial DNA copy number, and reaction conditions on the emergence of false-positive mutant bands
120. Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: A case–control study
121. Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma
122. Desmoplakin and KIF20B as target antigens in patients with paroxysmal nocturnal haemoglobinuria
123. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
124. The B-Cell Receptor Antigen ARS2 Can be Integrated into a BAR-Body Format to Treat Diffuse Large B-Cell Lymphomas in Xenograft Mouse Models
125. Role of FDG PET/CT to Detect Bone Marrow Involvement in the Initial Staging of Aggressive Non-Hodgkin Lymphoma
126. Unresolved issues in diffuse large B-cell lymphomas
127. Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cells
128. Differential Therapy for Diffuse Large B-Cell Lymphoma with Different Cells of Origin
129. Detection of Meningeosis neoplastica by real-time quantitation of telomerase activity
130. Mantle Cell Lymphoma: Biological Insights and Treatment Advances
131. HEMATOLOGY: Germinal center or nongerminal center DLBCL?
132. Role of perforin, granzymes and the proliferative state of the target cells in apoptosis and necrosis mediated by bispecific-antibody-activated cytotoxic T cells
133. Onkologie ’96
134. Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cells
135. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas
136. Rapid reconstitution of CMV-specific T-cells after stem-cell transplantation
137. Different expression of TNF and interleukin 8 in polymorphic neutrophils (PMN) of SAPHO patients due to interleukin 17 blocking agent
138. Progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders: A preliminary study
139. Status of Bispecific Monoclonal Antibodies for Cancer Therapy
140. Human tumor antigens recognized by antibodies (SEREX)
141. Aspects of Chemotherapy Schedules in Young and Elderly Patients with Aggressive Lymphoma
142. Identification of antigenic targets of paraproteins by expression cloning does not support a causal role of chronic antigenic stimulation in the pathogenesis of multiple myeloma and MGUS
143. Mitofilin and titin as target antigens in melanoma-associated retinopathy
144. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: Results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group
145. Rituximab for the treatment of diffuse large B-cell lymphomas
146. Serological immune response to cancer testis antigens in patients with pancreatic cancer
147. Factors predictive for response of follicular and mantle-cell lymphoma to rituximab
148. Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer
149. B-cell epitopes from the cancer testis antigen NY-ESO-1
150. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: Early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.